Abstract:Chronic obstructive pulmonary disease (COPD) is caused by the chronic inhalation of toxic particles and gases that are primarily but not exclusively derived from cigarette smoke that may be either actively or passively inhaled, which initiates a persistent innate and adaptive immune response in the lung. This immune response is associated with an aberrant tissue repair and remodeling process that results in varying degrees of chronic inflammation with excess production of mucus in the central airways and permanent destruction of the smaller conducting airways and gas exchanging surface in the peripheral lung. Currently, the primary aims of treatment in COPD are bronchodilation (inhaled short- and long-acting β-agonist and antimuscarinic therapies), to control symptoms and nonspecific broad-acting anti-inflammatory agents (inhaled and oral corticosteroids, phosphor-di-esterase inhibitors, and macrolides). That provide symptomatic relief but have little or no impact on either disease progression or mortality. As our understanding of the immune pathogenesis of the COPD improves, available immune modulation therapies have the potential to alter or interfere with damaging immune pathways, thereby slowing relentless progression of lung tissue destruction. The purpose of this brief review is to discuss our current understanding of the immune pathogenesis of both the airways and parenchymal injury as well as the dysfunctional tissue repair process to propose immune modulating interventions in an attempt to stabilize or return these pathological changes to their normal state. The ultimate goal of the immune modulation therapy is to improve both morbidity and mortality associated with COPD.<br/>Respiration

7. Immunologic lung disease

The Lung in Dysregulated States of Humoral Immunity

T-cell immunology of the lung: maintaining the balance between host defence and immune pathology

Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine

Physiological and immunological barriers in the lung

The Origin and Role of Innate Lymphoid Cells in the Lung

Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung

A cellular census of healthy lung and asthmatic airway wall identifies novel cell states in health and disease

Viral infection of the lung: host response and sequelae

Remodeling and Restraining Lung Tissue Damage Through the Regulation of Respiratory Immune Responses

Innate Lymphoid Cells of the Lung.

Cytokines and Lung Injury

The lung as a target organ in patients with hematologic disorders

Innate immune responses in pneumonia

Immune-mediated lung diseases: A narrative review

[Lung involvement in hematologic systemic diseases]

The innate immune function of airway epithelial cells in inflammatory lung disease

Chemotherapy-induced lung disease

The Roles of Tissue-Resident Memory T Cells in Lung Diseases

Immune-Modulation in Chronic Obstructive Pulmonary Disease: Current Concepts and Future Strategies

Potential Role of CC Chemokines and Their Receptors in the Development of Respiratory Diseases